Related Experiment Video
Updated: Jul 5, 2026
17:42
A Method for Murine Islet Isolation and Subcapsular Kidney Transplantation
Published on: April 13, 2011
Islet Transplantation in the UK.
1Director of the Oxford DRWF Islet Isolation Facility, Director of the Islet Transplant Programme, and Chair of the NHSBT UK Islet Steering Group, Nuffield Department of Surgical Sciences, University of Oxford, Oxford Centre for Diabetes, Endocrinology, and Metabolism, Churchill Hospital, Oxford, UK.
Cellr4-- Repair, Replacement, Regeneration, & Reprogramming
|September 16, 2021
Summary
The UK Islet Transplant Programme has advanced, demonstrating the success of beta-cell therapies. It is recommended that other nations establish similar, fully funded islet cell programs for broader patient access.
Area of Science:
- Endocrinology
- Transplantation Immunology
- Regenerative Medicine
Background:
- The UK Islet Transplant Programme has progressed significantly.
- Beta-cell replacement therapy offers a potential cure for type 1 diabetes.
- Current challenges include donor organ availability and long-term graft survival.
Purpose of the Study:
- To review the development and current status of the UK Islet Transplant Programme.
- To advocate for the establishment of similar fully funded beta-cell programs internationally.
- To highlight the potential of islet transplantation as a viable treatment option.
Main Methods:
- This is a commentary, not an experimental study.
- It synthesizes existing data and clinical experience from the UK programme.
- It draws upon the author's expertise in islet transplantation.
Main Results:
- The UK Islet Transplant Programme has achieved notable successes.
- The commentary provides a comprehensive overview of the programme's evolution.
- Key milestones and outcomes are discussed.
Conclusions:
- The UK model provides a strong foundation for international adoption.
- Fully funded beta-cell programs are crucial for advancing islet transplantation globally.
- Widespread implementation could significantly improve outcomes for patients with type 1 diabetes.
